A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women

被引:21
|
作者
Cozier, Yvette C. [1 ]
Barbhaiya, Medha [2 ]
Castro-Webb, Nelsy [1 ]
Conte, Carolyn [1 ]
Tedeschi, Sara [3 ]
Leatherwood, Cianna [3 ]
Costenbader, Karen H. [3 ]
Rosenberg, Lynn [1 ]
机构
[1] Boston Univ, Slone Epidemiol Ctr, 72 East Concord St, Boston, MA 02118 USA
[2] Hosp Special Surg, Dept Med, Div Rheumatol, 535 E 70th St, New York, NY 10021 USA
[3] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA
关键词
Obesity; Body Mass Index; Systemic lupus erythematosus; Prospective; Risk factor; Black women; BODY-MASS INDEX; WEIGHT-GAIN; RHEUMATOID-ARTHRITIS; SOCIOECONOMIC-STATUS; PSORIATIC-ARTHRITIS; AUTOIMMUNE-DISEASES; WAIST CIRCUMFERENCE; REVISED CRITERIA; DIETARY PATTERNS; ADIPOSE-TISSUE;
D O I
10.1016/j.semarthrit.2018.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity may influence systemic lupus erythematous (SLE) pathogenesis via stimulation of systemic inflammation, but the relationship between obesity and SLE risk is unclear. Past studies have predominantly assessed White women, while Black women have higher prevalence of both obesity and SLE. Methods: We prospectively assessed the relationship between Body Mass Index (BMI, kg/m(2)) and incident SLE within the Black Women's Health Study (median age 38 at entry in 1995). Height and weight at age 18 and during follow-up were self-reported. We confirmed incident SLE cases by updated American College of Rheumatology criteria and collected covariates prospectively. Cox proportional hazards regression models, adjusted for potential confounders, estimated hazard ratios (HRs) and 95% confidence intervals (Cis) for categories of updated BMI and risk of SLE, relative to BMI 20-24.9 ("normal" BMI). Secondary analyses investigated BMI at age 18, BMI in 1995 at cohort entry, cumulative updated BMI and "lagged" BMI (>= 4 years prior to outcome window to address possible reverse causation). Results: Adult obesity was not related to SLE risk: HR for BMI >= 30 ("obesity") relative to normal BMI at >= 4 years prior to SLE diagnosis was 0.90 (95% CI 0.53-1.54). However, obesity at age 18 was associated with increased risk: HR 2.38 (95% CI 1.26-4.51) for >= 30 vs. normal BMI. Conclusions: Among these Black women, obesity as a teenager was associated with increased SLE risk in adulthood. Further studies are necessary to understand the biologic mechanisms and windows of exposure for the relationship of obesity to SLE pathogenesis. (C) 2018 Elsevier Inc. All rights reserved.
引用
下载
收藏
页码:1030 / 1034
页数:5
相关论文
共 50 条
  • [41] Menopause and systemic lupus erythematosus (SLE)
    Huong, DLT
    Boddaert, J
    Andreu, MR
    Wechsler, B
    Amoura, Z
    Godeau, P
    Piette, JC
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S583 - S583
  • [42] Management of systemic lupus erythematosus (SLE)
    Morton, SJ
    Powell, RJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (05): : 686 - 693
  • [43] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419
  • [44] Treatment in systemic lupus erythematosus (SLE).
    Schroder, JO
    AKTUELLE RHEUMATOLOGIE, 1996, 21 (02) : 89 - 97
  • [45] Myositis in Systemic Lupus Erythematosus (SLE)
    Niaki, Omid
    Pineau, Christian
    Vinet, Evelyne
    Grenier, Louis-Pierre
    Kalache, Fares
    Nashi, Emil
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 795 - 795
  • [46] DEVELOPMENT OF ATHEROSCLEROSIS IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): THE CONTRIBUTION OF CLASSIC FRAMINGHAM RISK FACTORS
    Ahmad, Y.
    Bodill, H.
    El-Magadmi, M.
    Walker, M. G.
    Bernstein, R. M.
    Shelmerdine, J.
    Bruce, I. N.
    RHEUMATOLOGY, 2003, 42 : 77 - 77
  • [47] Pyuria in systemic lupus erythematosus (SLE)
    Bernatsky, Sasha
    Appenzeller, Simone
    Pineau, Christian A.
    Young, Claire L.
    Clarke, Ann E.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1175 - 1175
  • [48] Contraception in Systemic Lupus Erythematosus (SLE)
    Shaukat, Faizan
    Keeling, Stephanie
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2019, 5 (04) : 346 - 362
  • [49] Etiopathogenesis of systemic lupus erythematosus (SLE)
    Herrmann, M
    Voll, RE
    Kolowos, W
    Lorenz, HM
    Kalden, JR
    IMMUNOLOGIST, 2000, 8 (03): : 66 - 71
  • [50] Hypertrichosis in systemic lupus erythematosus (SLE)
    Santiago, M
    Travassos, AC
    Rocha, MC
    Souza, S
    CLINICAL RHEUMATOLOGY, 2000, 19 (03) : 245 - 246